» Articles » PMID: 31112121

United States Life Tables, 2016

Overview
Date 2019 May 22
PMID 31112121
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives-This report presents complete period life tables for the United States by race, Hispanic origin, and sex, based on age-specific death rates in 2016. Methods-Data used to prepare the 2016 life tables are 2016 final mortality statistics; July 1, 2016 population estimates based on the 2010 decennial census; and 2016 Medicare data for persons aged 66-99. The methodology used to estimate the life tables for the Hispanic population remains unchanged from that developed for the publication of life tables by Hispanic origin for data year 2006. The methodology used to estimate the 2016 life tables for all other groups was first implemented with data year 2008. Results-In 2016, the overall expectation of life at birth was 78.7 years, unchanged from 2015. Between 2015 and 2016, life expectancy at birth decreased by 0.1 year for males (76.3 to 76.2) and did not change for females (81.1). Life expectancy at birth did not change for the white population (78.9) between 2015 and 2016. Life expectancy at birth decreased by 0.2 year for the black population (75.5 to 75.3) and for the non-Hispanic black population (75.1 to 74.9). Life expectancy at birth decreased by 0.1 year for the non-Hispanic white population (78.7 to 78.6) and for the Hispanic population (81.9 to 81.8).

Citing Articles

Disparities in Social Vulnerability and Premature Mortality among Decedents with Hepatitis B, United States, 2010-2019.

Ly K, Yin S, Spradling P J Racial Ethn Health Disparities. 2024; .

PMID: 38472630 PMC: 11390983. DOI: 10.1007/s40615-024-01968-4.


Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures.

Ruhling S, Schwarting J, Froelich M, Loffler M, Bodden J, Petzsche M Front Endocrinol (Lausanne). 2023; 14:1222041.

PMID: 37576975 PMC: 10422975. DOI: 10.3389/fendo.2023.1222041.


Declining life expectancy in the Great Lakes region: contributors to Black and white longevity change across educational attainment.

Roberts M, Lim S, Reither E BMC Public Health. 2023; 23(1):769.

PMID: 37098511 PMC: 10130305. DOI: 10.1186/s12889-023-15668-x.


A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.

Monfared A, Ye W, Sardesai A, Folse H, Chavan A, Aruffo E Neurol Ther. 2023; 12(3):863-881.

PMID: 37009976 PMC: 10195966. DOI: 10.1007/s40120-023-00473-w.


Estimated Societal Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.

Monfared A, Ye W, Sardesai A, Folse H, Chavan A, Kang K Neurol Ther. 2023; 12(3):795-814.

PMID: 36929345 PMC: 10195963. DOI: 10.1007/s40120-023-00460-1.